---
figid: PMC3772104__jkst-2-e24137-g2
figlink: /pmc/articles/PMC3772104/figure/F2/
number: F2
caption: Figure 2. Proposed mechanism of JAK-STAT involvement in atopic dermatitis
  (AD) development, part II. Here, Th2 cells play a significant role. By their abilities
  to provide IL-4 and IL-5 stimulation via the JAK-STAT pathway, immature B cells
  could be differentiated into mature B cell and plasma cells would undergo antibody
  heavy chain switching to IgE class. The subsequent binding of IgE to skin mast cells
  could lead to release of histamine, which is known to exacerbate AD. Similarly,
  this hyper Th2 immune milieu, particularly IL-4, could trigger epidermal cells to
  produce and release various chemokines (such as CCL26), pro-inflammatory cytokines,
  and angiogenic factors, leading to AD pathophysiology. Moreover, IL-5 released from
  this hyper Th2 milieu could, through JAK-STAT pathway, activate eosinophils, and
  attract them to the skin via CCL26, further worsening the AD condition. In addition,
  by way of IL-31, an inducer of pruritus, AD symptoms could become increasingly intensified.
  Black arrows indicate activation pathway. Red lines indicate inhibition pathway.
pmcid: PMC3772104
papertitle: The involvement of the JAK-STAT signaling pathway in chronic inflammatory
  skin disease atopic dermatitis.
reftext: Lei Bao, et al. JAKSTAT. 2013 Jul 1;2(3):e24137.
pmc_ranked_result_index: '21835'
pathway_score: 0.9568429
filename: jkst-2-e24137-g2.jpg
figtitle: Involvement of the JAK-STAT signaling pathway in chronic inflammatory skin
  disease atopic dermatitis
year: '2013'
organisms:
- Homo sapiens
ndex: 1c4d0223-dee4-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3772104__jkst-2-e24137-g2.html
  '@type': Dataset
  description: Figure 2. Proposed mechanism of JAK-STAT involvement in atopic dermatitis
    (AD) development, part II. Here, Th2 cells play a significant role. By their abilities
    to provide IL-4 and IL-5 stimulation via the JAK-STAT pathway, immature B cells
    could be differentiated into mature B cell and plasma cells would undergo antibody
    heavy chain switching to IgE class. The subsequent binding of IgE to skin mast
    cells could lead to release of histamine, which is known to exacerbate AD. Similarly,
    this hyper Th2 immune milieu, particularly IL-4, could trigger epidermal cells
    to produce and release various chemokines (such as CCL26), pro-inflammatory cytokines,
    and angiogenic factors, leading to AD pathophysiology. Moreover, IL-5 released
    from this hyper Th2 milieu could, through JAK-STAT pathway, activate eosinophils,
    and attract them to the skin via CCL26, further worsening the AD condition. In
    addition, by way of IL-31, an inducer of pruritus, AD symptoms could become increasingly
    intensified. Black arrows indicate activation pathway. Red lines indicate inhibition
    pathway.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFC
  - VEGFA
  - PPBP
  - PGF
  - PF4
  - CCL24
  - JAK1
  - VEGFB
  - VEGFD
  - CXCL2
  - IL4
  - CCL2
  - JAK2
  - TYK2
  - CCL26
  - CXCL8
  - STAT3
  - CXCL9
  - CXCL1
  - JAK3
  - CXCL6
  - STAT6
  - IL1B
  - IL27
  - CXCL13
  - STAT4
  - IL5
  - IL19
  - IL1A
  - IL31
  - CXCL14
  - CXCL3
  - STAT2
  - CXCL10
  - STAT1
  - CXCL12
  - CXCL5
  - STAT5A
  - CXCL11
  - STAT5B
  - Histamine
genes:
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFC
  entrez: '7424'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PPBP
  entrez: '5473'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: PGF
  entrez: '5228'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: PF4
  entrez: '5196'
- word: CCL24,CCL26,etc.
  symbol: CCL24
  source: hgnc_symbol
  hgnc_symbol: CCL24
  entrez: '6369'
- word: JAK1
  symbol: JAK1
  source: hgnc_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFB
  entrez: '7423'
- word: VEGF,
  symbol: VEGF
  source: bioentities_symbol
  hgnc_symbol: VEGFD
  entrez: '2277'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL2
  entrez: '2920'
- word: IL-4,
  symbol: IL-4
  source: hgnc_alias_symbol
  hgnc_symbol: IL4
  entrez: '3565'
- word: MCP-1,
  symbol: MCP-1
  source: hgnc_alias_symbol
  hgnc_symbol: CCL2
  entrez: '6347'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: TYK2
  entrez: '7297'
- word: CCL24,CCL26,etc.
  symbol: CCL26
  source: hgnc_symbol
  hgnc_symbol: CCL26
  entrez: '10344'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL8
  entrez: '3576'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT3
  entrez: '6774'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL9
  entrez: '4283'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL1
  entrez: '2919'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK3
  entrez: '3718'
- word: JAK
  symbol: JAK
  source: bioentities_symbol
  hgnc_symbol: JAK1
  entrez: '3716'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL6
  entrez: '6372'
- word: STAT6
  symbol: STAT6
  source: hgnc_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: IL-1,
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1B
  entrez: '3553'
- word: JAK2/
  symbol: JAK2
  source: hgnc_symbol
  hgnc_symbol: JAK2
  entrez: '3717'
- word: IL-1,IL-19,IL-27,etc.
  symbol: IL27
  source: hgnc_symbol
  hgnc_symbol: IL27
  entrez: '246778'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL13
  entrez: '10563'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT4
  entrez: '6775'
- word: IL-4,IL-5
  symbol: IL-5
  source: hgnc_alias_symbol
  hgnc_symbol: IL5
  entrez: '3567'
- word: IL-1,IL-19,IL-27,etc.
  symbol: IL-19
  source: hgnc_alias_symbol
  hgnc_symbol: IL19
  entrez: '29949'
- word: IL-1,
  symbol: IL1
  source: bioentities_symbol
  hgnc_symbol: IL1A
  entrez: '3552'
- word: IL-31
  symbol: IL-31
  source: hgnc_alias_symbol
  hgnc_symbol: IL31
  entrez: '386653'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL14
  entrez: '9547'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL3
  entrez: '2921'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT2
  entrez: '6773'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL10
  entrez: '3627'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT1
  entrez: '6772'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL12
  entrez: '6387'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL5
  entrez: '6374'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5A
  entrez: '6776'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT6
  entrez: '6778'
- word: Chemokines
  symbol: Chemokine
  source: bioentities_symbol
  hgnc_symbol: CXCL11
  entrez: '6373'
- word: STAT
  symbol: STAT
  source: bioentities_symbol
  hgnc_symbol: STAT5B
  entrez: '6777'
chemicals:
- word: Histamine
  source: MESH
  identifier: D006632
diseases: []
figid_alias: PMC3772104__F2
redirect_from: /figures/PMC3772104__F2
figtype: Figure
---
